1. Home
  2. PHIN vs NVAX Comparison

PHIN vs NVAX Comparison

Compare PHIN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIN
  • NVAX
  • Stock Information
  • Founded
  • PHIN 2023
  • NVAX 1987
  • Country
  • PHIN United States
  • NVAX United States
  • Employees
  • PHIN N/A
  • NVAX N/A
  • Industry
  • PHIN
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PHIN
  • NVAX Health Care
  • Exchange
  • PHIN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • PHIN 1.8B
  • NVAX 2.0B
  • IPO Year
  • PHIN N/A
  • NVAX 1995
  • Fundamental
  • Price
  • PHIN $50.52
  • NVAX $8.81
  • Analyst Decision
  • PHIN Buy
  • NVAX Buy
  • Analyst Count
  • PHIN 2
  • NVAX 6
  • Target Price
  • PHIN $53.50
  • NVAX $17.83
  • AVG Volume (30 Days)
  • PHIN 543.8K
  • NVAX 4.5M
  • Earning Date
  • PHIN 02-13-2025
  • NVAX 02-26-2025
  • Dividend Yield
  • PHIN 1.98%
  • NVAX N/A
  • EPS Growth
  • PHIN N/A
  • NVAX N/A
  • EPS
  • PHIN 2.34
  • NVAX N/A
  • Revenue
  • PHIN $3,452,000,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • PHIN N/A
  • NVAX N/A
  • Revenue Next Year
  • PHIN $1.04
  • NVAX N/A
  • P/E Ratio
  • PHIN $21.57
  • NVAX N/A
  • Revenue Growth
  • PHIN N/A
  • NVAX N/A
  • 52 Week Low
  • PHIN $29.11
  • NVAX $3.53
  • 52 Week High
  • PHIN $57.23
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • PHIN 59.82
  • NVAX 49.69
  • Support Level
  • PHIN $46.74
  • NVAX $8.35
  • Resistance Level
  • PHIN $52.44
  • NVAX $9.14
  • Average True Range (ATR)
  • PHIN 1.21
  • NVAX 0.64
  • MACD
  • PHIN 0.58
  • NVAX -0.04
  • Stochastic Oscillator
  • PHIN 89.41
  • NVAX 30.28

About PHIN PHINIA Inc.

Phinia Inc is a leader in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications, and light vehicles. It is a global supplier to most major original equipment manufacturers (OEMs) and offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket. Phinia has an extensive original equipment portfolio of advanced fuel injection systems, fuel delivery modules, canisters, starters, alternators, sensors, electronic control modules, and associated software.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: